Inger Helene Mattsby Baltzer
Director/Miembro de la Junta en Fungea AB .
Perfil
Inger Helene Mattsby Baltzer is the founder of PharmaSurgics In Sweden AB, which was founded in 2005.
She is currently a Director at Fungea AB.
Cargos activos de Inger Helene Mattsby Baltzer
Empresas | Cargo | Inicio |
---|---|---|
Fungea AB
Fungea AB BiotechnologyHealth Technology Fungea AB engages in the development of tests to detect the presence of fungi, bacteria, or other microorganisms in humans and animals, food ingredients, or elsewhere in the environment. It specializes in commercial physical and biological research. The firm also develops probiotics and other methods to influence the microbial environment, production, and distribution of its products and consulting. The company was founded on June 19, 2006 and is headquartered in Nödinge, Sweden. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Inger Helene Mattsby Baltzer.
Empresas | Cargo | Fin |
---|---|---|
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
Fungea AB
Fungea AB BiotechnologyHealth Technology Fungea AB engages in the development of tests to detect the presence of fungi, bacteria, or other microorganisms in humans and animals, food ingredients, or elsewhere in the environment. It specializes in commercial physical and biological research. The firm also develops probiotics and other methods to influence the microbial environment, production, and distribution of its products and consulting. The company was founded on June 19, 2006 and is headquartered in Nödinge, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Inger Helene Mattsby Baltzer